In the U.S. there are just over 7,500 hospitals, and based on findings from a recent Surgical Products survey, as many as 4,500 of them could either be in the midst of
expansion or have experienced some form of it in the last
In assembling and evaluating the results, Surgical
Products focused on the significant amount of construction/
expansion taking place at hospitals and a shrinking number
of surgical centers around the country. We asked our readers
what types of investments were being made and how these
expenditures will impact their surgical capabilities. The survey’s key findings follow.
A Closer Look
When asked about recent expansion projects:
• More than 61 percent of respondents said they have seen
expansion construction take place at their facility within the
last two years.
• Additionally, nearly 55 percent are currently in the midst of
such a project.
• Over 68 percent stated that expansion will take place sometime over the next three years.
• All of these numbers represent significant increases from
one year ago.
In looking at individual responsibilities, 62 percent of those
responding had input before construction began or during
the expansion process. This includes product selection and
Respondent comments pointed to the most significant
investments being geared towards constructing more operating rooms, general infrastructure upgrades, more clinical
space and expanding emergency room capabilities. Of note,
Surgical suite expansion sees an uptick with an increased focus on ERs and pre-operative space as focal points for hospitals.
I made a change that
reduced HAIs in my hospital.
Sue Moeslein RN, MSA, CIC, Riverside Regional Medical Center
CDC statistics show that in the United States, 1 in every 25 patients
will contract a hospital acquired infection (HAI) costing upwards
of $30 billion annually, with close to 75,000 patients dying.
Our mission at Xenex is to eliminate the pathogens that cause
infections affecting the health and lives of millions of patients
and their families by providing the ONLY patented Full Spectrum TM
Pulsed Xenon UV Disinfection Robot.
1. Levin J, et al., Cooley Dickinson in AJIC 2013, 41:746-748. 2. Simmons
S, et al., Cone Health System in JIP 2013. 3. Stibich M, et al., M.D.
Anderson Cancer Center in ICHE 2011, 32:286-288.
Peer reviewed patient outcomes:
53% reduction in C. diff infection rates.1
57% reduction in MRSA infection rates. 2
100% elimination of VRE in isolation rooms. 3
Join Sue – Become a Face of Change Today.